Thyroid Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with medullary thyroid cancer (a specific type of thyroid cancer, sometimes called MTC) may be eligible for parts of this trial (Aims 1 and 2).
- People who are already registered in the Medullary Thyroid Cancer Registry (a database that tracks people with this condition) may be eligible for parts of this trial (Aims 1 and 2).
- People at any stage of their medullary thyroid cancer may be considered for Aims 1 and 2.
- People who have been diagnosed with advanced medullary thyroid cancer (classified as "red" or "gray" phase by their medical team) may be eligible for the third part of this trial (Aim 3).
- People who are currently registered in the Medullary Thyroid Cancer Registry may be eligible for the third part of this trial (Aim 3).
Who may not be able to join:
- People who do not have a diagnosis of medullary thyroid cancer may not meet the criteria for this trial.
- People who are not registered in the Medullary Thyroid Cancer Registry may not meet the criteria for this trial.
- People whose medullary thyroid cancer is not classified as advanced (red or gray phase) by their medical team may not meet the criteria for Aim 3 of this trial.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Elizabeth G Grubbs, M.D. Anderson Cancer Center
Phone: 713-792-6940
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Natural history of medullary thyroid cancer (MTC); Patients' experience with the different phases of MTC; Association of selected biometric and patient-reported outcomes
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.